Computer-Aided Self-Exposure Therapy for Phobia/Panic Disorder: A Pilot Economic Evaluation

$53.29 plus tax (Refund Policy)

Buy Article:

Abstract:

Phobia/panic disorder is common. It improves with exposure therapy, even when guided mainly by a computer self-help system such as FearFighter (FF), but such therapy must also demonstrate cost-effectiveness. This study compares the cost-effectiveness of FF with computed-aided relaxation and clinician-led exposure. Data were obtained on patients from a randomised controlled trial of FF. Economic analyses used pretreatment and 1-month follow-up self-ratings of the main problem and global phobia. Clinician costs were calculated using the number of therapist hours and the cost of FF. Incremental cost-effectiveness ratios were calculated and cost-effectiveness acceptability curves were produced. Data were available on 62 patients with main problem ratings and 60 with global phobia ratings. FF and clinician-led exposure were more effective than relaxation but more expensive. Compared with relaxation, producing an extra unit of improvement on the main problem scale cost £64 with FF and £100 with clinician-led exposure. FF appeared to be more cost-effective using the global phobia rating (£112 per extra unit of improvement vs. £128 for clinician-led exposure). The cost-effectiveness of FF could be enhanced if users had less highly trained supporters. FF would be less cost-effective if face-to-face therapy was delivered by less qualified professionals. Caution is urged regarding these indicative findings given that these were secondary analyses.

Keywords: cognitive behaviour therapy; economic evaluation; health care costs

Document Type: Research Article

DOI: http://dx.doi.org/10.1080/16506070802561074

Affiliations: 1: Centre for the Economics of Mental Health, Health Service and Population Research Department, Institute of Psychiatry, King's College London, London 2: Institute of Psychiatry, King's College London, London 3: Psychobiology of Anxiety and Obsessive-Compulsive Disorders Group, Section of Cognitive Neuropsychiatry, Institute of Psychiatry, King's College London, London 4: West London Mental Health Trust, London 5: St. Patrick's Hospital, Dublin, Ireland

Publication date: June 1, 2009

More about this publication?
Related content

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more